COMPANY RECORDS REVENUE OF $187.3 MILLION, NET INCOME OF $29.4 MILLION AND EPS OF $0.28 (BASIC) AND $0.26 (DILUTED) MARIETTA, Ga., Feb. 23, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ:  MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market […]